Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
The Keio Journal of Medicine|April 2, 2025
Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing SurgeryTomoko Seki, Yusuke Kobayashi, Kenta Masuda, et al.
Current Genomics|September 3, 2011
Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch SyndromeKenta Masuda, Kouji Banno, Megumi Yanokura, et al.
Bioscience, Biotechnology, and Biochemistry|June 30, 2015
Enhanced dipicolinic acid production during the stationary phase in Bacillus subtilis by blocking acetoin synthesisYoshihiro Toya, Takashi Hirasawa, Shu Ishikawa, et al.
Biochemistry Research International|May 2, 2012
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by EpigeneticsKouji Banno, Iori Kisu, Megumi Yanokura, et al.
Japanese Journal of Clinical Oncology|October 10, 2020
Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institutionYusuke Kobayashi, Akira Hirasawa, Tatsuyuki Chiyoda, et al.
International Journal of Oncology|January 28, 2015
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancerKiyoko Umene, Megumi Yanokura, Kouji Banno, et al.
Molecular and Clinical Oncology|July 24, 2014
Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review)Miho Iida, Kouji Banno, Megumi Yanokura, et al.
Molecular and Cellular Biology|January 29, 2014
Rad51-dependent aberrant chromosome structures at telomeres and ribosomal DNA activate the spindle assembly checkpointAkemi Nakano, Kenta Masuda, Taisuke Hiromoto, et al.
Oncology Reports|July 17, 2012
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cellsKenta Masuda, Kouji Banno, Megumi Yanokura, et al.
Pageof 10